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Introduction
Chlorinated dibenzo-p-dioxins have been
identified as trace contaminants of herbicides
and pesticides. They may be formed as by-
products in the manufacture of chlorinated
phenols and, for this reason, were impli-
cated in outbreaks of chick edema disease
(1). Fat trimmings obtained from animal
hides preserved with dioxin-containing chlor-
ophenol products and subsequently used in
chicken feed contained the chick edema fac-
tor. Chloracne had been earlier observed in
workers who had handled technical quality
2,4,5-trichlorophenol (2). Occasionally the
condition was complicated by liver involve-
ment and psychopathological changes. Pure
2,4,5-trichlorophenol had no effect when test-
ed in an animal bioassay system. Tetrachloro-
dibenzodioxin (TCDD), which was isolated
from the technical mixture, produced an ef-
fect at a concentration of 0.005%o, however
(13). In addition, TDCC is the contaminant
of the herbicide 2,4,5-T that produced tera-
togenic effects in rats (4). Subsequent work
with pure TCDD has indeed shown terato-
genic and embryotoxic effects in rats and
mice (5-7).
The fact that the chlorinated dioxins are
highly toxic, teratogenic, and acnegenic does
not of necessity indicate they are carcinogens
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as well. However in view of the widespread
use of products that might contain dioxins
as contaminants and their extreme stability
under environmental conditions, examination
of their possible long-term effects is impera-
tive. This program was initiated to determine
the chronic toxicity and potential carcino-
genicity of a series of chlorinated diben-
zodioxins by oral administration and skin
application. The unsubstituted, 2, 7-dichloro-
and octachlorodibenzodioxins are relatively
innocuous with regard to toxicity. The 2,3,7-
trichloro-, 2,3,7,8-tetrachloro- and hexa-
chlorodibenzodioxins, however, are quite
toxic and require the use of specialized facil-
ities to minimize the possibility of human
exposure. This report describes our results
to date with the nontoxic dioxins. Work is
being initiated with the toxic dioxins as they
become available.
Experimental
The octachlorodibenzodioxin used in these
studies was prepared by Spectratec Inc.,
Washington, D. C. The other dioxins were
synthesized by the Chemistry Division of
IIT Research Institute. Swiss-Webster and
B6C3F1 mice and Osborne-Mendel rats were
obtained from contract supported colonies
at Charles River Breeding Laboratories
through arrangement with the Mammalian
Genetics and Animal Production Section, Na-
tional Cancer Institute.
Skin carcinogenesis studies will be contin-
ued for a total of 78 weeks. Each treatment
September 1973 163group consists of 30 male and 30 female
Swiss-Webster mice that are shaved weekly.
In testing for complete carcinogenicity 0.2
ml of a solution of the test compound dis-
solved in acetone is applied three times week-
ly to the backs of mice. The octachloro-, di-
chloro-, and unsubstituted dibenzodioxin so-
lutions in acetone contain 0.2, 3.0, and 80
mg/ml, respectively. For the study of pro-
motion activity, each mouse was initially
treated with 50 jg dimethylbenzanthracene
(DMBA) 1 week prior to initiation of test
compound application.
Osborne-Mendel rats and B6C3F1 mice
are being used in the oral administration
studies. Groups of 50 male and 50 female mice
and 35 male and 35 female rats are receiving
the dioxins at levels of 1%o and 0.5%o of the
diet, and similar groups are receiving 1o
and 0.5%o dioxane in their drinking water.
In the case of the supposedly nontoxic oc-
tachlorodibenzodioxin, in which numerous
animal deaths occured after 20 weeks of
feeding, additional animals were placed on
test at lower dietary levels.
Results
The results for the skin carcinogenesis
study to date are shown in Table 1. None
of the dioxin-treated mice in the complete
carcinogenesis study exhibited skin tumors,
although subcutaneous tumors are present
in two mice treated with octachlorodibenzo-
dioxin. Histopathological results are not yet
available for all mice that have died. Of those
that have been examined, however, a malign-
ant lymphoma of the lymphocyte type was
found in a mouse treated with unsubstituted
dioxin. No other significant lesions were
found in any of the mice from the complete
study.
The promotion study has yielded apparent
skin tumors in male mice treated with un-
substituted dibenzodioxin or dichlorodibenzo-
dioxin. As the animals showing these skin
lesions are still alive, histologic confirma-
tions of this observation is not yet available.
A plasmacytoma has been found in one mouse
from the dichlorodibenzodioxin promotion
group.
Acetone was originally included in the
complete study as a solvent control, since the
dioxins are dissolved in it for skin applica-
tion. No skin tumors have been found in
either surviving mice or in tissue from
those that have died. The acetone promotion
groups, however, were started 3 months lat-
er, and skin tumors have been confirmed by
microscopic examination of skin of a male
mouse that died. A reticulum cell malign-
ant lymphoma was found in one of the fe-
males that was examined, but there were no
other significant lesions.
The dioxins can be considered as deriva-
tives of 1,4-dioxane, and this compound was
included in the studies because of the struc-
tural similarity. One carcinoma not micro-
scopically confirmed and a subcutaneous
tumor are apparent in the surviving mice
of the complete study. Tissues from those
that died revealed a reticulum cell malignant
lymphoma but no evidence of skin lesions.
The dioxane promotion groups are of par-
ticular interest since their response unex-
pectedly rivaled that of the croton oil posi-
tive controls in both mortality and mice
exhibiting papillomas. The activity of croton
oil and dioxane as promoting agents fol-
lowing DMBA initiation is shown in Figures
1 and 2. Weekly counts of papillomas and
suspect carcinomas were made by gross ex-
amination. The fraction of mice bearing skin
tumors is nearly identical for both materials,
as is the time course for tumor development
(Fig. 1). However, croton oil treatment led
to a much higher multiplicity of skin tumors
per mouse than did treatment with dioxane
(Fig. 2). Carcinomas were produced in both
treatment groups in direct proportion to
the number of papillomas present.
Histopathological results from the two
treatments differed in that effects observed
with croton oil were primarily neoplastic.
A majority of the dioxane-treated mice had
liver lesions of a mild nature (megalocyto-
sis, occasional distended bile canaliculi, occas-
ional necrotic centrolobular necrosis, cuffed
triad vessels, general mononuclear periportal
infiltration, and mild peripherolobular fibro-
sis). The distribution of preneoplastic and
Environmental Health Perspectives 1640
0.4 e g F 8 ;00
d~ U 4 04 o ; c4o co 4 o
co co Cs co Cs0 0 ci0 ~~ o~
O XO a tE O' F.;O A O 0- Aa 04'~~04 ~ Ca' 0 4 0) 0 4.. 04 040 04
0bH 0H O 0o H O Oo 004 I o Cs o
Z3 ~~ ~~ Zi Z o Z3 ZY~~-4 Z3i 93 .
04a COyI0001 l0 00c000o0~i
o0 00 0 o oo Ceo
0 00 00 o CDO
I 0 0 o C4Q 0o o -I0 CD oo o C
I 00 o= Lo 00 000 0 o 0 o N
°00c "
I toO 0 d U: tf O C U t400 O to N qLO Cq czaCq c N CQ ,- Cq cq CCC O N N Cq CQ C
r7t4rz t4 X tr4 r24 4 x4z4t r44
° ffi o ~00 m t t CQ O O 0 o to o to 0 o
V VP
P 0 0 0 -4 0 00
.2 ~~ 0 0 0 2. . ~.
- 0 - 0~k 0 - - 0 -
04 04~0 0 0 u 0
0
ao O 0
ON
0
is o8
P~H
Po
1
d la uiO
0
'o
*_
0 0
O
la
0 0
0
a o
wo u V a 04
0)
0
0
September 1973
4N
C: a)
a-
._4
b o
0
0
04
a)
0
04 04
a)
0
n
N 0
*5
05
to
;o3
0
0
$
a)rJ
go
.0
Wi
m :
04-
Oi
0
0
0
a)
A 0
z
.4
a)
I
0. co
0i
U,
a-
0
N a)
C02
0
aL)
co
a-4 E-4
0
0 0 0:4
0 0
165so
E
6C
i._
cn
',
nr
10 20 30
Weeks Of Promotion
FIGURE 1. Comparative rate of promotion activity
for croton oil and dioxane on male mice.
neoplastic lesions in the dioxane-treated
group is shown in Table 2. In treated skin,
conditions ranged from hyperplasia to der-
mal fibrosarcoma. Squamous cell carcinoma
of the nasal septum was observed in one
animal which had skin papilloma. Of nine
mice with lung tumors, seven had malig-
nant lung lesions, of which three were con-
sidered metastatic from other sites.
The average weights of controls and test
animals receiving the dioxins in their diet
and dioxane in water are shown in Figures
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FIGURE 2. Promotion activity of 1%/ croton oil and
dioxane on Swiss-Webster mice.
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FIGURE 3. Average weight of treated female and
male rats.
3 and 4 for rats and Figures 5 and 6 for
mice. The stimulatory effect of dioxane on
weight gain in male mice and rats is most
interesting, especially in view of the skin
carcinogenesis results. The effect is not as
marked in females; however, after 10 weeks
the weight gain of female mice at 0.5%o ex-
ceeds that of the controls. Generally, the
dioxins cause a decrease in growth rate al-
though dichlorodibenzodioxin, which has not
been on test as long as the other compounds,
does not appear to affect growth rate at the
levels tested.
A summary of the results to date in the
feeding studies is shown in Table 3. Despite
the stimulation of growth in surviving ani-
mals, dioxane has caused an appreciable
mortality in rats but has had little effect
on mice. Chronic bronchopneumonia and
chronic murine pneumonia above the back-
ground level were the major changes observ-
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166Table 2. Distribution of preneoplastic and neoplastic lesions in 15 mice treated witn
dioxane following DMBA initiation.
Number of mice with specific lesions
Nasal Pericar-
Type of lesion Skin septum Trachea Lung Spleen Kidney Liver dium
Hypertrophy and/or 6 1
hyperplasia
Papilloma 2
Carcinoma itn situ 1
Squamous cell 2 1 2
carcinoma
Bronchial adeno- 3
matiod lesion
Alveolar adenoma 4
Bronchiolar or 3
alveolar carcinoma
Fibrosarcoma 3 1 1
Undifferentiated 1 1 1
sarcoma
Malignant lymphoma
Lymphocyte type 1 1 1 1
Reticulum cell 1 1 1
sarcoma
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FIGURE 4. Average weight of treated female and
male rats.
ed in the rats that have been examined. Ap-
preciable mortality has also been observed
in female mice that are receiving 1%o unsub-
stituted dioxin. Hepatotoxicity was the maj-
or effect noted, but one mouse exhibited
broncheolar mucosal hyperplasia. The rats
that receivedthis compound exhibited hepato-
toxicity and chronicmurinepneumonia.
Toxicity in animals fed octachlorodioxin
was evidenced by both growth depression
and mortality. A distinct difference in the
susceptibility of the sexes to the compound
was observed for mice and rats. Thus all
male mice died by 10 and 8 weeks, respective-
ly, in the 1% and 0.5%b levels while, at 37
weeks, there were 5 female 1%o survivors
and 45 female survivors at 0.5%o. On the
other hand, all female rats died by 22 and
25 weeks, respectively, in the 1%o and 0.5%o
groups while the last males died at 32 and
37 weeks. New test groups were -set up at
0.25% for all animals and at 0.125%o for fe-
male rats and male mice since these groups
appeared to be more drug-sensitive. Even
at these lower dose levels, all of the mice
have died.
Rats and mice fed octachlorodibenzodioxin
had changes ranging from early hepatotoxic
September 1973 167Table 3. Summary of dioxin oral administration data.
Rats (35 per group) Mice (50 per group)
Significant Significant
Week pathology Week pathology
of Survivors of
Compound Sex test Lung Liver test Survivors Lung Liver
Controls M 34 35 31 50
F 34 35 31 50
1%to Dioxane M 42 24 8/11 1/11 40 50
F 42 20 3/5 2/5 43 49
0.5% Dioxane M 42 26 6/6 1/6 40 49
F 42 32 3/3 1/3 43 49
1% Unsubstituted M 42 33 2/2 2/2 39 48
dibenzodioxin F 42 32 1/2 2/2 39 29 3/14 7/14
0.5% Unsubstituted M 42 31 3/4 1/4 34 50
dibenzodioxin F 42 35 39 49
1% Dichloro- M 17 35 17 49 0/1 0/1
dibenzodioxin F 17 35 17 48 1/2 1/2
0.5% Dichloro- M 17 35 17 50
dibenzodioxin F 17 35 17 49
1% Octachloro- M 32 0 1/5 5/5 10 0 0/5 5/5
dibenzodioxin F 22 0 0/5 5/5 37 5 0/5 6/6
0.5% Octachloro- M 37 0 1/5 5/5 8 0 0/5 5/5
dibenzodioxin F 25 0 37 45
0.25% Octachloro- M 17 28 1/2 2/2 17 1
dibenzodioxin F 17 15 0/3 3/3 15 0 2/2 1/2
0.1259% Octachloro- M - 9 0
diobenzodioxin F 17 30
lesions (diffuse vacuolar degeneration, fatty
metamorphosis, megalocytosis, necrosis, and
cholangiolar epithelial hyperplasia) to cir-
chosis with disrupted lobule architecture,
necrosis, fibrosis, parenchymal regeneration
and cholangiolar proliferation. There were
areas of bronchiolar mucosal hyperplasia in
the lungs of two rats, and one of these rats
also had bronchiolar adenomatoid lesions. In
one mouse, there were bronchiolar mucosal
hyperplasia and metaplasia and one bron-
chiolar carcinoma in which signs of early
squamous change could be seen.
Discussion
The preliminary results reported here are
by no means conclusive with regard to the
carcinogenicity of the chlorinated dioxins.
The oral studies indicate primarily hepato-
toxicity, especially in the case of octachloro-
dibenzodioxin. A supplementary analysis
report from Midwest Research Institute pro-
vides a possible explanation for some of
the toxicity observed. The batch of octach-
lorodibenzodioxin used in preparation of the
diets was found to contain hexachlorodiben-
zodioxin at a level of less than 0.1So. A
dietary level of 1 o octachlorodibenzodioxin
which contained this contaminant would pro-
vide a hexachlorodibenzodioxin intake of
approximately 150 jug/day for rats and 50
ptg/day for mice. Chronic toxicity values for
this compound are not available. However,
in preliminary experiments at Dow Chemi-
cal Co. (5), hexachlorodibenzodioxin at 100
1Ag/kg/day for 10 days caused growth depres-
sion, liver pathology, and embryotoxicity
in rats. Tests with animals receiving the
first batch of octachlorodibenzodioxin will
continue as long as there are survivors. Addi-
tional groups of animals at dietary levels of
0.5%o and 0.25%o octachlorodibenzodioxin
shown on analysis not to contain the hexa-
chlorodibenzodioxin contaminant have been
started. After 6 weeks, many of the male
mice at 0.5% have died, thereby indicating
Environmental Health Perspectives 1684
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FIGURE 5. Average weight of treated female and
male mice.
possible toxicity of the octachlorodibenzo-
dioxin itself. A comparative feeding and in-
tubation study is currently underway to
determine if the octachloro causes a decrease
in dietary intake.
The skin carcinogenesis assay for the
nontoxic compounds is nearing completion,
and no skin tumors have been observed in
the complete carcinogenesis studies. The na-
ture of the internal growths must be de-
termined at necropsy. The fact that only male
mice have exhibited skin tumors in the pro-
motion studies can probably be attributed to
the additional factor of wounding. As the
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FIGURE 6. Average weight of treated female and
male mice.
mice are housed in groups of 10, there is
considerable fighting amongthe males, result-
ing in scars on the backs of the less aggres-
sive animals. Boutwell (8) has shown that
wound healing plays an integral role in the
promotion of skin carcinogenesis, and fight-
ing among males treated with unsubstituted
and dichlorodibenzodioxin as well as ace-
tone may have contributed to the promotion
of skin tumors. No explanation can be given
at this time for the lack of tumors in the
octachlorodioxin group, since this compound
was also dissolved in acetone.
The positive control group treated with
September 1973 169DMBA and croton oil responded as expected
in terms of skin tumor promotion. The extent
and variety of the lesions produced by
DMBA and dioxane were unexpected, how-
ever, previous studies have shown dioxane to
be a hepatocarcinogen (9) and to induce
carcinomas in the nasal cavity of rats re-
ceiving dioxane in drinking water (10).
No previous reports of dioxane as a promot-
ing agent in skin carcinogenesis could be
found. Because of the use of dioxane as a
solvent in industry and in histology labora-
tories for tissue processing, the results ob-
tained are of potential significance in rela-
tion to possible carcinogenic hazards to
humans.
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